Androgen Deprivation Therapy and Cataract Incidence Among Elderly Prostate Cancer Patients in the United States Jennifer Beebe-Dimmer, PhD, Hal Morgenstern, PhD, Karynsa Cetin, MPH, Cecilia Yee, MS, Monina Bartoces, PhD, Vahakn Shahinian, MD, Jon Fryzek, PhD, John Acquavella, PhD, Kendra L. Schwartz, MD Annals of Epidemiology Volume 21, Issue 3, Pages 156-163 (March 2011) DOI: 10.1016/j.annepidem.2010.10.003 Copyright © 2011 Elsevier Inc. Terms and Conditions
Figure 1 Prostate cancer patients participating in SEER-Medicare study. Annals of Epidemiology 2011 21, 156-163DOI: (10.1016/j.annepidem.2010.10.003) Copyright © 2011 Elsevier Inc. Terms and Conditions
Figure 2 Unadjusted cataract-free survival among ADT users and nonusers according to history of cataract before the diagnosis of prostate cancer. Annals of Epidemiology 2011 21, 156-163DOI: (10.1016/j.annepidem.2010.10.003) Copyright © 2011 Elsevier Inc. Terms and Conditions